Why the study?
Does intravenous ICI 141,292 alter immediate haemodynamic parameters compared to atenolol in healthy volunteers and patients with ischaemic heart disease?
Population
8 healthy young volunteers and 6 patients with ischaemic heart disease (total n=14)
Comparison
Intravenous ICI 141,292 vs Intravenous atenolol 5 mg (in healthy volunteers)
Design
RCT, randomised crossover, double-blind
Follow-up
Immediate
Authors
Loading...
Supports acute beta1-blockade with ISA for exercise HR control in IHD; extends haemodynamic data on this agent versus healthy volunteers.
Does intravenous ICI 141,292 alter immediate haemodynamic parameters compared to atenolol in healthy volunteers and patients with ischaemic heart disease?
ICI 141,292 is a potent beta 1-adrenoceptor blocking agent with moderate intrinsic sympathomimetic activity that effectively reduces heart rate and blood pressure during exercise.
Bonde et al. (1987) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: